CA2415260A1 - Methodes de criblage des acides nucleiques par spectrometrie de masse - Google Patents

Methodes de criblage des acides nucleiques par spectrometrie de masse Download PDF

Info

Publication number: CA2415260A1
Authority: CA; Canada
Prior art keywords: mass; nucleic acid; target nucleic; sample; stranded
Prior art date: 1996-03-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002415260A

Other languages

English (en)

Inventor

Joseph A. Monforte

Thomas A. Shaler

Yuping Tan

Christopher H. Becker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sequenom Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-04

Filing date

1997-03-04

Publication date

1997-09-12

1997-03-04 Application filed by Individual filed Critical Individual

1997-03-04 Priority claimed from CA002248084A external-priority patent/CA2248084A1/fr

1997-09-12 Publication of CA2415260A1 publication Critical patent/CA2415260A1/fr

Status Abandoned legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 309
102000039446 nucleic acids Human genes 0.000 title claims abstract description 280
108020004707 nucleic acids Proteins 0.000 title claims abstract description 280
238000000034 method Methods 0.000 title claims abstract description 199
238000012216 screening Methods 0.000 title claims abstract description 19
238000004949 mass spectrometry Methods 0.000 title claims description 85
230000035772 mutation Effects 0.000 claims abstract description 164
108020004414 DNA Proteins 0.000 claims description 91
238000003776 cleavage reaction Methods 0.000 claims description 79
230000007017 scission Effects 0.000 claims description 77
125000003729 nucleotide group Chemical group 0.000 claims description 70
150000003839 salts Chemical class 0.000 claims description 70
108091008146 restriction endonucleases Proteins 0.000 claims description 51
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 44
239000000203 mixture Substances 0.000 claims description 36
102000053602 DNA Human genes 0.000 claims description 26
239000000126 substance Substances 0.000 claims description 18
BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 claims description 16
101710163270 Nuclease Proteins 0.000 claims description 14
238000001704 evaporation Methods 0.000 claims description 14
108020004682 Single-Stranded DNA Proteins 0.000 claims description 13
239000011159 matrix material Substances 0.000 claims description 13
238000005406 washing Methods 0.000 claims description 13
230000029087 digestion Effects 0.000 claims description 12
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 6
229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 6
235000012538 ammonium bicarbonate Nutrition 0.000 claims description 6
239000001099 ammonium carbonate Substances 0.000 claims description 6
OWSUFPNEINDECW-UHFFFAOYSA-N carbonic acid;n-methylmethanamine Chemical compound C[NH2+]C.OC([O-])=O OWSUFPNEINDECW-UHFFFAOYSA-N 0.000 claims description 5
230000003247 decreasing effect Effects 0.000 claims description 5
238000010438 heat treatment Methods 0.000 claims description 5
ARGNFRQXCRRALH-UHFFFAOYSA-N hydrogen carbonate;trimethylazanium Chemical compound CN(C)C.OC(O)=O ARGNFRQXCRRALH-UHFFFAOYSA-N 0.000 claims description 5
KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 claims 2
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims 1
239000000523 sample Substances 0.000 description 251
239000012634 fragment Substances 0.000 description 250
238000006062 fragmentation reaction Methods 0.000 description 57
238000013467 fragmentation Methods 0.000 description 55
230000000295 complement effect Effects 0.000 description 48
239000000047 product Substances 0.000 description 47
239000007787 solid Substances 0.000 description 46
239000002773 nucleotide Substances 0.000 description 43
238000013459 approach Methods 0.000 description 42
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 38
238000001819 mass spectrum Methods 0.000 description 36
238000004458 analytical method Methods 0.000 description 35
239000000243 solution Substances 0.000 description 31
239000003153 chemical reaction reagent Substances 0.000 description 30
238000003752 polymerase chain reaction Methods 0.000 description 30
108090000623 proteins and genes Proteins 0.000 description 29
102000004533 Endonucleases Human genes 0.000 description 28
108010042407 Endonucleases Proteins 0.000 description 27
238000009396 hybridization Methods 0.000 description 27
238000006243 chemical reaction Methods 0.000 description 26
239000007790 solid phase Substances 0.000 description 23
108091034117 Oligonucleotide Proteins 0.000 description 21
229960002685 biotin Drugs 0.000 description 21
239000011616 biotin Substances 0.000 description 21
235000020958 biotin Nutrition 0.000 description 20
239000011324 bead Substances 0.000 description 18
239000013615 primer Substances 0.000 description 18
102000004190 Enzymes Human genes 0.000 description 17
108090000790 Enzymes Proteins 0.000 description 17
238000003199 nucleic acid amplification method Methods 0.000 description 17
238000001228 spectrum Methods 0.000 description 17
230000003321 amplification Effects 0.000 description 16
238000000746 purification Methods 0.000 description 16
238000012163 sequencing technique Methods 0.000 description 16
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 15
238000012986 modification Methods 0.000 description 15
150000002500 ions Chemical class 0.000 description 14
230000005291 magnetic effect Effects 0.000 description 14
230000008569 process Effects 0.000 description 14
239000002253 acid Substances 0.000 description 13
238000002955 isolation Methods 0.000 description 13
230000004048 modification Effects 0.000 description 13
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
230000008859 change Effects 0.000 description 12
239000000499 gel Substances 0.000 description 12
238000001502 gel electrophoresis Methods 0.000 description 12
230000003595 spectral effect Effects 0.000 description 12
-1 salt ions Chemical class 0.000 description 11
108091028043 Nucleic acid sequence Proteins 0.000 description 10
239000000872 buffer Substances 0.000 description 10
238000010586 diagram Methods 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 9
108010090804 Streptavidin Proteins 0.000 description 9
239000001226 triphosphate Substances 0.000 description 9
235000011178 triphosphate Nutrition 0.000 description 9
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
238000003556 assay Methods 0.000 description 8
238000001514 detection method Methods 0.000 description 8
125000005647 linker group Chemical group 0.000 description 8
229910052760 oxygen Inorganic materials 0.000 description 8
238000001712 DNA sequencing Methods 0.000 description 7
108020005187 Oligonucleotide Probes Proteins 0.000 description 7
230000008901 benefit Effects 0.000 description 7
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 7
230000002068 genetic effect Effects 0.000 description 7
239000000463 material Substances 0.000 description 7
239000002751 oligonucleotide probe Substances 0.000 description 7
238000011282 treatment Methods 0.000 description 7
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
150000007513 acids Chemical class 0.000 description 6
238000000137 annealing Methods 0.000 description 6
210000001072 colon Anatomy 0.000 description 6
230000037430 deletion Effects 0.000 description 6
238000012217 deletion Methods 0.000 description 6
238000004925 denaturation Methods 0.000 description 6
230000036425 denaturation Effects 0.000 description 6
230000002255 enzymatic effect Effects 0.000 description 6
239000012535 impurity Substances 0.000 description 6
238000010348 incorporation Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
238000003780 insertion Methods 0.000 description 6
238000002372 labelling Methods 0.000 description 6
238000001556 precipitation Methods 0.000 description 6
235000021251 pulses Nutrition 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
108700024394 Exon Proteins 0.000 description 5
239000012491 analyte Substances 0.000 description 5
238000005520 cutting process Methods 0.000 description 5
238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
108010064144 endodeoxyribonuclease VII Proteins 0.000 description 5
230000008020 evaporation Effects 0.000 description 5
102000040430 polynucleotide Human genes 0.000 description 5
108091033319 polynucleotide Proteins 0.000 description 5
239000002157 polynucleotide Substances 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000000926 separation method Methods 0.000 description 5
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 5
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
108091026890 Coding region Proteins 0.000 description 4
108020004705 Codon Proteins 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
108060002716 Exonuclease Proteins 0.000 description 4
101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
238000012408 PCR amplification Methods 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 4
102000005891 Pancreatic ribonuclease Human genes 0.000 description 4
238000007846 asymmetric PCR Methods 0.000 description 4
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
230000008878 coupling Effects 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
238000013461 design Methods 0.000 description 4
238000000502 dialysis Methods 0.000 description 4
238000000132 electrospray ionisation Methods 0.000 description 4
102000013165 exonuclease Human genes 0.000 description 4
238000001914 filtration Methods 0.000 description 4
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
229910052737 gold Inorganic materials 0.000 description 4
239000010931 gold Substances 0.000 description 4
230000003993 interaction Effects 0.000 description 4
238000007834 ligase chain reaction Methods 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
108700025694 p53 Genes Proteins 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
102000054765 polymorphisms of proteins Human genes 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 4
229940104230 thymidine Drugs 0.000 description 4
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108010086093 Mung Bean Nuclease Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
230000000692 anti-sense effect Effects 0.000 description 3
238000003491 array Methods 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
239000000356 contaminant Substances 0.000 description 3
229940104302 cytosine Drugs 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
229920002401 polyacrylamide Polymers 0.000 description 3
239000012286 potassium permanganate Substances 0.000 description 3
230000008685 targeting Effects 0.000 description 3
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 3
YRMCHMPUELTEAJ-WOSRLPQWSA-N 1-[(2s,4s,5r)-2-hept-1-ynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1=CC(=O)NC(=O)N1[C@@]1(C#CCCCCC)C[C@H](O)[C@@H](CO)O1 YRMCHMPUELTEAJ-WOSRLPQWSA-N 0.000 description 2
JSZPBTUOIOMFMS-UHFFFAOYSA-N 2-hydroperoxyoxolane Chemical compound OOC1CCCO1 JSZPBTUOIOMFMS-UHFFFAOYSA-N 0.000 description 2
LTNXPAWXDXNMCV-BFHYXJOUSA-N 5-hept-2-ynyl-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(CC#CCCCC)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 LTNXPAWXDXNMCV-BFHYXJOUSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
108090001008 Avidin Proteins 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
201000003883 Cystic fibrosis Diseases 0.000 description 2
108020001019 DNA Primers Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
230000007023 DNA restriction-modification system Effects 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108091027568 Single-stranded nucleotide Proteins 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
229910052770 Uranium Inorganic materials 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
239000012148 binding buffer Substances 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
239000010949 copper Substances 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
238000003795 desorption Methods 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000005342 ion exchange Methods 0.000 description 2
238000004255 ion exchange chromatography Methods 0.000 description 2
229910052742 iron Inorganic materials 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
230000004807 localization Effects 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 2
229910052759 nickel Inorganic materials 0.000 description 2
229940046166 oligodeoxynucleotide Drugs 0.000 description 2
239000012285 osmium tetroxide Substances 0.000 description 2
229910000489 osmium tetroxide Inorganic materials 0.000 description 2
230000005298 paramagnetic effect Effects 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000002987 primer (paints) Substances 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
230000009467 reduction Effects 0.000 description 2
239000010703 silicon Substances 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
238000010532 solid phase synthesis reaction Methods 0.000 description 2
238000004611 spectroscopical analysis Methods 0.000 description 2
239000010959 steel Substances 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
238000001269 time-of-flight mass spectrometry Methods 0.000 description 2
230000007704 transition Effects 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
YRCRRHNVYVFNTM-UHFFFAOYSA-N 1,1-dihydroxy-3-ethoxy-2-butanone Chemical compound CCOC(C)C(=O)C(O)O YRCRRHNVYVFNTM-UHFFFAOYSA-N 0.000 description 1
NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 1
ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101710134784 Agnoprotein Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
241001227713 Chiron Species 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
230000008836 DNA modification Effects 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical group CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
108091064358 Holliday junction Proteins 0.000 description 1
102000039011 Holliday junction Human genes 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
241001521291 Morus bassanus Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101710149086 Nuclease S1 Proteins 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
108091093037 Peptide nucleic acid Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
208000032236 Predisposition to disease Diseases 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
108010065868 RNA polymerase SP6 Proteins 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
108091036333 Rapid DNA Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 description 1
238000002679 ablation Methods 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
150000001615 biotins Chemical class 0.000 description 1
238000009835 boiling Methods 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
238000001818 capillary gel electrophoresis Methods 0.000 description 1
KDJVUTSOHYQCDQ-UHFFFAOYSA-N carbamic acid;1h-imidazole Chemical compound NC([O-])=O.[NH2+]1C=CN=C1 KDJVUTSOHYQCDQ-UHFFFAOYSA-N 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000005289 controlled pore glass Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
229910001873 dinitrogen Inorganic materials 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000005684 electric field Effects 0.000 description 1
238000000119 electrospray ionisation mass spectrum Methods 0.000 description 1
230000002616 endonucleolytic effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
238000007306 functionalization reaction Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
238000010448 genetic screening Methods 0.000 description 1
239000011544 gradient gel Substances 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
150000007857 hydrazones Chemical class 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
229910001410 inorganic ion Inorganic materials 0.000 description 1
229950001103 ketoxal Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
238000002966 oligonucleotide array Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
229910052762 osmium Inorganic materials 0.000 description 1
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000002245 particle Substances 0.000 description 1
238000005192 partition Methods 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
229910052761 rare earth metal Inorganic materials 0.000 description 1
150000002910 rare earth metals Chemical class 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000007480 sanger sequencing Methods 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
238000004513 sizing Methods 0.000 description 1
238000010583 slow cooling Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
239000000758 substrate Substances 0.000 description 1
QXKXDIKCIPXUPL-UHFFFAOYSA-N sulfanylidenemercury Chemical compound [Hg]=S QXKXDIKCIPXUPL-UHFFFAOYSA-N 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000009121 systemic therapy Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000001196 time-of-flight mass spectrum Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

CA002415260A 1996-03-04 1997-03-04 Methodes de criblage des acides nucleiques par spectrometrie de masse Abandoned CA2415260A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1275296P	1996-03-04	1996-03-04
US60/012,752		1996-03-04
CA002248084A CA2248084A1 (fr)	1996-03-04	1997-03-04	Methodes de criblage des acides nucleiques par spectrometrie de masse

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002248084A Division CA2248084A1 (fr)	1996-03-04	1997-03-04	Methodes de criblage des acides nucleiques par spectrometrie de masse

Publications (1)

Publication Number	Publication Date
CA2415260A1 true CA2415260A1 (fr)	1997-09-12

Family

ID=25680506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002415260A Abandoned CA2415260A1 (fr)	1996-03-04	1997-03-04	Methodes de criblage des acides nucleiques par spectrometrie de masse

Country Status (1)

Country	Link
CA (1)	CA2415260A1 (fr)

1997
- 1997-03-04 CA CA002415260A patent/CA2415260A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
2003-03-19	EEER	Examination request
2005-03-04	FZDE	Dead

Publication	Publication Date	Title
US6051378A (en)	2000-04-18	Methods of screening nucleic acids using mass spectrometry
US6566055B1 (en)	2003-05-20	Methods of preparing nucleic acids for mass spectrometric analysis
JP3437184B2 (ja)	2003-08-18	切断可能なプライマーを用いるオリゴヌクレオチドサイズ計測
US6235476B1 (en)	2001-05-22	Process for detecting nucleic acids by mass determination
WO1998012355A1 (fr)	1998-03-26	Procedes de preparation d'acides nucleiques pour des analyses de spectrometrie de masse
US9051608B2 (en)	2015-06-09	Detection and quantification of biomolecules using mass spectrometry
US8133701B2 (en)	2012-03-13	Detection and quantification of biomolecules using mass spectrometry
EP2099934B1 (fr)	2012-05-30	Détection et quantification de biomolécules à l'aide de la spectrométrie de masse
Jurinke et al.	1996	Analysis of ligase chain reaction products via matrix-assisted laser Desorption/Ionization time-of-Flight–Mass spectrometry
CN105229170B (zh)	2019-12-20	通过基于结构的探针切割的核酸靶鉴定
JP2001524808A (ja)	2001-12-04	放出可能な不揮発性の質量標識分子
JP2006271382A (ja)	2006-10-12	質量分析に基づいたｄｎａ診断
Guo	1999	Mass spectrometry in DNA analysis
EP3194613B1 (fr)	2019-01-30	Identification de cible d'acide nucléique par clivage de sonde reposant sur une structure
CA2415260A1 (fr)	1997-09-12	Methodes de criblage des acides nucleiques par spectrometrie de masse
HK1126821A (en)	2009-09-11	Dna diagnostics based on mass spectrometry